SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review

Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 8(30), p. 567-579, 2020

Journal article published in 2020 by José Adão Carvalho Nascimento Junior

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by